Simon Shaw

Simon Shaw is an experienced professional in the pharmaceutical industry, with a background in organic chemistry and a PhD from Imperial College London. Simon has held various positions at Rigel Pharmaceuticals Inc., Kosan Biosciences, and Princeton University, focusing on the development of novel pharmaceuticals in areas such as anti-infectives and oncology. At Princeton University, Simon conducted research in carbohydrate synthesis and modified vancomycin derivatives.